The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen ...

LONDON, Sept. 12, 2023 /PRNewswire/ -- Virax Biolabs Group Limited (VRAX), an innovative diagnostics company focused on the detection of immune responses and diagnosis of viral diseases, announced ...

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a “masked T-cell engager”. This type of immunotherapy ignites our own ...

Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before. This breakthrough may help explain why immunotherapy works for some ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...

In patients with autoimmune hemolytic anemia (AIHA), the risk of relapse is high owing to persistent autoreactive B-cell activity. Multirefractory AIHA is a more advanced stage of disease that is ...